EUVIMEDEUVIMED entdecken
Crossref

BioJect: An in vitro platform to explore release dynamics of peptides in subcutaneous drug delivery

David Li, Qiuhua Qin, Ayça Altay Benetti, Lyes Kahouadji, Matthias G Wacker

Journal of Controlled Release · 2025-04 · 380 · 1058-1079

DOI: 10.1016/j.jconrel.2025.02.013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Controlled Release, 2025-04. Verfasst von David Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy and Pharmaceutical Sciences, National University of Singapore, Singapore. Hauptthemen laut MEDLINE: Insulin, Drug Delivery Systems, Peptides, Hypoglycemic Agents. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 111 Literaturangaben. Gefördert von: Government of Singapore Ministry of Education, National University of Singapore.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Predicting the release performance of subcutaneous (SC) drug formulations is challenging due to the complex interplay between physicochemical properties and the physiological microenvironment, which includes the extracellular matrix (ECM), fluid composition, and fluid availability, factors that collectively influence bioavailability and absorption rates. The ECM often acts as a bandpass filter modulated by local ion and protein content. In this study, we introduce the BioJect cell, a modern release test method based on the compendial flow-through cell, integrating a perfusion system with customizable biomatrix components. We systematically investigated the release mechanisms of four insulin formulations: regular human insulin, insulin aspart, insulin glulisine, and Neutral Protamine Hagedorn (NPH) insulin. A modified simulated subcutaneous interstitial fluid (mSSIF) comprising multiple components of the SC physiological environment was employed. It incorporates important ions and proteins (138.5 mM sodium, 10 mM potassium, 1.8 mM calcium, 0.8 mM magnesium, 111.3 mM chloride, 28 mM bicarbonate, 0.5 mM sulfate, 5 mM acetate, 4.2 mM phosphate, 30 g/L total protein added as bovine serum albumin). Our release test method discriminated the tested formulations under varying biorelevant conditions, demonstrating its biopredictive capabilities. Notably, we discovered a previously undocumented albumin binding affecting the release rate of insulin glulisine, likely occurring in the low-shear environment of SC tissue only. Additionally, the inclusion of biorelevant components like hyaluronic acid and collagen into the biomatrix of the BioJect cell provided profound insights into potential absorption and release mechanisms, supported by two in vitro-in vivo relationships (level C and level A). The BioJect cell represents a significant advancement in simulating the SC environment for drug release testing. Our findings highlight the importance of considering protein binding and ECM components in predicting drug absorption, offering a promising tool for the development and optimization of SC formulations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

InsulinDrug Delivery SystemsPeptidesHypoglycemic AgentsHumansDrug LiberationInjections, SubcutaneousAnimalsExtracellular Matrix

Stichwörter der Autor:innen

ADMEAbsorptionBiopredictiveBiorelevantDiffusion assayDissolutionDrug release assayIVIVCIn vitro-in vivo relationship (IVIVR)Non-oral complex drugsPeptidesPerformance TestingSubcutaneous (SC)

Substanzen

InsulinPeptidesHypoglycemic Agents

Autor:innen und Institutionen

  • Department of Pharmacy and Pharmaceutical Sciences, National University of Singapore, Singapore.
  • Department of Chemical Engineering, Imperial College London, London, United Kingdom.
  • Department of Pharmacy and Pharmaceutical Sciences, National University of Singapore, Singapore. Electronic address: matthias.g.wacker@nus.edu.sg.

Förderung

  • Government of Singapore Ministry of Education
  • National University of Singapore

Zitieren

APA

Li, D., Qin, Q., Benetti, A. A., Kahouadji, L., & Wacker, M. G. (2025). BioJect: An in vitro platform to explore release dynamics of peptides in subcutaneous drug delivery. Journal of Controlled Release, 380, 1058-1079. https://doi.org/10.1016/j.jconrel.2025.02.013

Vancouver

Li D, Qin Q, Benetti AA, Kahouadji L, Wacker MG. BioJect: An in vitro platform to explore release dynamics of peptides in subcutaneous drug delivery. Journal of Controlled Release. 2025;380:1058-1079. doi:10.1016/j.jconrel.2025.02.013

BibTeX
@article{Li2025,
  author = {Li, David and Qin, Qiuhua and Benetti, Ayça Altay and Kahouadji, Lyes and Wacker, Matthias G},
  title = {BioJect: An in vitro platform to explore release dynamics of peptides in subcutaneous drug delivery},
  journal = {Journal of Controlled Release},
  year = {2025},
  volume = {380},
  pages = {1058--1079},
  doi = {10.1016/j.jconrel.2025.02.013}
}
Kostenlos starten →